Overview

Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Status:
Recruiting

Trial end date:
2021-12-12

Target enrollment:

Participant gender:

Summary

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

Phase:

Phase 4

Details

Lead Sponsor:

Usama Azhar

Collaborator:

King Edward Medical University

Treatments:

Fluticasone
Montelukast
Xhance